JMCR Partners

JMCR Partners operates as an investment firm, primarily functioning as a family office that manages the private assets of its founder's family and close relations. The firm, also known as JMCR Family Office, deploys capital through affiliated vehicles like JMCR Capital and JMRE. Their investment strategy focuses on private equity, quantitative strategies, and real assets. They have a particular interest in life sciences and technology ventures, aiming to identify and support promising ventures across various stages of development.

Established in 2013, JMCR Partners was founded by biotech entrepreneur Jun Mao. The firm's inception was driven by the need to manage the Mao family's global assets, expanding to include investments for close relations. It operates with the philosophy that effective asset management for others stems from first successfully managing one's own, building a foundation of trust and expertise.

JMCR Partners has made several investments, with a portfolio that includes companies such as Eubulus Biotherapeutics, Tekeluo Biotech, Viva Biotech, Riparian Pharmaceuticals, and Bonti. Their investments have spanned various stages, including early-stage venture capital and Series B rounds, particularly within the biotechnology and life sciences sectors. The firm typically invests in deals ranging from 1 to 10 million dollars.

The firm's team includes its founder, Jun Mao, a seasoned biotech entrepreneur. JMCR Partners has cultivated a stable network with an elite team across its offices in Hong Kong, London, and Boston, leveraging their collective expertise in private equity and quantitative investment strategies to drive successful outcomes for their portfolio companies.